Alkylating agents as leukemogens in multiple myeloma.
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007938:Leukemia / Q000139:chemically induced*; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D008297:Male; D008558:Melphalan / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*
D000477:Alkylating Agents; D003520:Cyclophosphamide; D008558:Melphalan